PSTV (STOCKS)
PLUS THERAPEUTICS, Inc. Common Stock
$0.267200
-0.004000 (-1.47%)
Prev close: $0.271200
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Marc H. Hedrick
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $47.87M
- Employees
- 21
- P/E (TTM)
- -0.14
- P/B (TTM)
- 7.06
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.04 | $-0.02 | -0.0196 | -96.08% |
|
Jun 2025 (Q2)
|
$0.02 | $-0.09 | +0.1118 | +121.79% |
|
Mar 2025 (Q1)
|
$-1.19 | $-0.15 | -1.0404 | -695.45% |
|
Dec 2024 (Q4)
|
$-0.49 | $-0.51 | +0.0166 | +3.28% |
Financial Statements
| Revenues | $5.26M |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $18.71M |
| Nonoperating Income/Loss | -$7.12M |
| Operating Expenses | $18.71M |
| Research and Development | $7.62M |
| Other Operating Expenses | $11.09M |
| Operating Income/Loss | -$13.46M |
| Income/Loss From Continuing Operations After Tax | -$20.58M |
| Income/Loss From Continuing Operations Before Tax | $5.26M |
| Net Income/Loss | -$20.58M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$20.58M |
| Net Income/Loss Available To Common Stockholders, Basic | -$15.53M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | -$5.05M |
| Preferred Stock Dividends And Other Adjustments | -$5.05M |
| Basic Earnings Per Share | -$1.03 |
| Diluted Earnings Per Share | -$1.21 |
| Basic Average Shares | 132,259,222 |
| Diluted Average Shares | 131,099,530 |
| Assets | $18.67M |
| Current Assets | $17.59M |
| Noncurrent Assets | $1.08M |
| Fixed Assets | $273.00K |
| Other Non-current Assets | $811.00K |
| Liabilities | $13.62M |
| Current Liabilities | $13.62M |
| Noncurrent Liabilities | $0.00 |
| Equity | $5.05M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $5.05M |
| Liabilities And Equity | $18.67M |
| Net Cash Flow From Operating Activities | -$15.73M |
| Net Cash Flow From Operating Activities, Continuing | -$15.73M |
| Net Cash Flow From Investing Activities | $287.00K |
| Net Cash Flow From Investing Activities, Continuing | $287.00K |
| Net Cash Flow From Financing Activities | $27.51M |
| Net Cash Flow From Financing Activities, Continuing | $27.51M |
| Net Cash Flow | $12.07M |
| Net Cash Flow, Continuing | $12.07M |
| Comprehensive Income/Loss | -$20.58M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$20.58M |
| Other Comprehensive Income/Loss | $0.00 |